Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3Jennifer M. Atkinson, Márcio F. Chedid|PLoS ONE|2015Cited by 107